# Vor Biopharma (stock symbol: VOR) Logo in transparent PNG and SVG formats

## Vor Biopharma Logo large

### Vor Biopharma Logo large Download PNG (39.93 KB)

![Vor Biopharma Logo large Download PNG (39.93 KB)](/img/orig/VOR_BIG-ec519058.png)

### Vor Biopharma Logo large Download SVG (1.67 KB)

![Vor Biopharma Logo large Download SVG (1.67 KB)](/img/orig/VOR_BIG-8dc1b0f0.svg)

## Vor Biopharma Logo icon format

### Vor Biopharma Logo icon format Download PNG (57.49 KB)

![Vor Biopharma Logo icon format Download PNG (57.49 KB)](/img/orig/VOR-ec3e38c0.png)

### Vor Biopharma Logo icon format Download SVG (984 Bytes)

![Vor Biopharma Logo icon format Download SVG (984 Bytes)](/img/orig/VOR-dbf588ee.svg)

## Vor Biopharma Logo large for dark backgrounds

### Vor Biopharma Logo large for dark backgrounds Download PNG (24.45 KB)

![Vor Biopharma Logo large for dark backgrounds Download PNG (24.45 KB)](/img/orig/VOR_BIG.D-d1cf1f6e.png)

### Vor Biopharma Logo large for dark backgrounds Download SVG (1.64 KB)

![Vor Biopharma Logo large for dark backgrounds Download SVG (1.64 KB)](/img/orig/VOR_BIG.D-a21681a5.svg)

## Vor Biopharma Logo icon format for dark backgrounds

### Vor Biopharma Logo icon format for dark backgrounds Download PNG (35.8 KB)

![Vor Biopharma Logo icon format for dark backgrounds Download PNG (35.8 KB)](/img/orig/VOR.D-7094c977.png)

### Vor Biopharma Logo icon format for dark backgrounds Download SVG (967 Bytes)

![Vor Biopharma Logo icon format for dark backgrounds Download SVG (967 Bytes)](/img/orig/VOR.D-2eed50af.svg)

## About Vor Biopharma

Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML blood cancer cells. The company's eHSCs targeted therapies, such as CAR-Ts, bispecific antibodies, and antibody-drug conjugates provide treatment for blood cancers. Vor Biopharma, Inc. has a collaboration agreement with Akron BioProducts to develop and manufacture cGMP nucleases. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

1. Website domain: vorbio.com
2. Employees: 135
3. Marketcap: $0.29 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
